Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated:
a. HbA1c was significantly reduced
b. Pediatric Time in Range improved by 3.7 hours/day after 3 months use
c. Hypoglycemia remained low
d. All of the above

Submit is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation and Medtronic.
©2022 CogniMed Inc. All rights reserved.